Market Overview

Why Livongo Health's Stock Is Trading Higher Today


Livongo Health (NASDAQ: LVGO) shares are trading higher on Tuesday after DA Davidson initiated coverage on Teladoc with a Buy rating and $250 price target. Teladoc and Livongo announced a merger agreement this year.

Livongo Health provides a data science and technology enabled platform for detection of diabetes. Its additional solutions include Livongo for Hypertension, Livongo for Prediabetes and Weight Management, and Livongo for Behavioral Health by myStrength. The company's client comprise of employers, health plans, government entities, and labor unions. Its operations are primarily located in the United States.

Livongo Health shares were trading up 5.42% at $137.59 on Tuesday at the time of publication. The stock has a 52-week high of $150 and a 52-week low of $15.12.

Latest Ratings for LVGO

Oct 2020JP MorganDowngradesOverweightNeutral
Aug 2020StifelDowngradesBuyHold
Aug 2020Canaccord GenuityMaintainsBuy

View More Analyst Ratings for LVGO
View the Latest Analyst Ratings


Related Articles (LVGO)

View Comments and Join the Discussion!

Posted-In: why it's movingInitiation Analyst Ratings

Latest Ratings

INTCJP MorganMaintains70.0
STMCanaccord GenuityMaintains47.0
ELDeutsche BankMaintains248.0
UAADeutsche BankMaintains13.0
INTCDeutsche BankMaintains55.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at